Safi Shahda is an Oncology physician affiliated with Indiana University Health. OpenAlex indexes 139 publications with 2,363 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
535 Barnhill Dr Rm 473
Indianapolis, IN 462025116
Telephone
317-274-5000Registry record last updated 7 Mar 2019.
Clinical trials
- Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer
Sponsor: Hoosier Cancer Research Network
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
47.1%Antidiarrheal microorganisms20.2%Creon100%Part D<11 patientsPotassium supplement15.4%Klor-Con M20100%Part D<11 patients+ 1 more class in this area
Blood & clotting
28.8%Factor Xa inhibitor28.8%Xarelto100%Part D<11 patientsNervous system
24%Phenothiazine13.5%Prochlorperazine Maleate100%Part D<11 patientsAtypical Antipsychotic10.6%Olanzapine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy
New England Journal of Medicine
2025 - Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin
Journal of Cachexia Sarcopenia and Muscle
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Zipes, MD
Indiana University Health
Lawrence Einhorn, MD
Indiana University Health
Lisa Landrum, MD
Indiana University Health
Patrick Loehrer, MD
Indiana University Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”